Dimensional Fund Advisors LP Novavax Inc Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $1.9 Million - $3.94 Million	-52,359 Reduced 83.28%	10,513 $541,000
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $1.9 Million - $3.89 Million	-27,247 Reduced 30.23%	62,872 $4.63 Million
Q4 2021 Feb 09, 2022	SELL	$134.56 - $217.97 $24,220 - $39,234	-180 Reduced 0.2%	90,119 $12.9 Million
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $2.17 Million - $3.3 Million	-12,213 Reduced 11.91%	90,299 $18.7 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $913,913 - $1.95 Million	7,553 Added 7.95%	102,512 $21.8 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $252,058 - $713,763	-2,231 Reduced 2.3%	94,959 $17.2 Million
Q4 2020 Feb 25, 2021	BUY	$78.74 - $139.5 $7.65 Million - $13.6 Million	97,190 New	97,190 $10.8 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.